Lets Gel Kit Interactions
There are 109 drugs known to interact with Lets Gel Kit (epinephrine / lidocaine / tetracaine topical), along with 7 disease interactions. Of the total drug interactions, 9 are major, and 100 are moderate.
- View Lets Gel Kit disease interactions (7)
Medications known to interact with Lets Gel Kit
Note: Showing generic names only.
A
B
C
- carteolol
- carteolol ophthalmic
- carvedilol
- chloroprocaine
- chloroquine
- cocaine nasal
- cocaine topical
- cyclophosphamide
D
E
F
H
I
- ifosfamide
- indacaterol
- isocarboxazid
- isoetharine
- isoniazid
- isoproterenol
- isosorbide
- isosorbide dinitrate
- isosorbide mononitrate
K
L
M
- mepivacaine
- metaproterenol
- methylene blue
- methylergonovine
- methysergide maleate
- metipranolol ophthalmic
- metoclopramide
- mexiletine
- midodrine
- milnacipran
N
O
P
- penbutolol
- phenazopyridine
- phenelzine
- phenobarbital
- phenytoin
- pindolol
- pirbuterol
- prilocaine
- primaquine
- procaine
- procaine penicillin
- procarbazine
- propranolol
Q
R
S
- safinamide
- salmeterol
- selegiline
- sibutramine
- silver nitrate topical
- silver sulfadiazine topical
- sodium nitrite
- solriamfetol
- sotalol
- sulfadiazine
- sulfamethizole
- sulfamethoxazole
- sulfasalazine
- sulfisoxazole
T
- tafenoquine
- tapentadol
- terbutaline
- tetracaine
- timolol
- timolol ophthalmic
- tocainide
- tolcapone
- tranylcypromine
V
Lets Gel Kit disease interactions
There are 7 disease interactions with Lets Gel Kit (epinephrine / lidocaine / tetracaine topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- dehydration
- acidosis
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.